DIAGNOSIS AND TREATMENT

The Global Longevity Institute pursues its mission through a wide range of activities. It carries out original researches and analysis on issues related to global aging. It publishes information, articles and presentations that communicate its findings and recommendations to the broadest possible audience.

GLI organizes and hosts conferences and forums that bring together science experts for constructive dialog about the scope of the global aging challenge and the most effective ways of the prolongation of life. Scientists and clinicians work together to identify and test dietary, pharmacological, regenerative and biotechnology, physical activity and engineering approaches to prevent multiple diseases of aging and maximize healthspan.

We are working in the synergism created by the various laboratories from 5 medical company and attracting leading scientists interested in a longevity research-centered approach to improve human health.

With anti-aging medical checkup, the GLI medical specialists will address potential threats to your health and check your aging progress, to provide you with a one-on-one custom health care program to keep you healthy.

GLI anti-aging and medical checkup programme is aimed at revitalising the entire body and suspension the ageing process.

Anti-aging and Medical Checkup includes:

The liver is the largest internal organ in the human body and its proper function is indispensable for many critical metabolic functions, including the regulation of lipid and sugar metabolism, the production of important proteins, including those involved in blood clotting, and purification of blood. There are over 100 described diseases of the liver, and because of its many functions, these can be highly debilitating and life-threatening unless effectively treated.

Liver diseases can result from injury to the liver caused by a variety of insults, including hepatitis C virus (HCV), hepatitis B virus (HBV), obesity, chronic excessive alcohol use or autoimmune diseases. Many people with active liver disease remain undiagnosed largely because liver disease patients are often asymptomatic for many years. According to the European Association for the Study of the Liver (EASL), 29 million Europeans have chronic liver disease, and liver disease represents approximately two percent of deaths annually. In studies has been shown that in obese people hepatic tissue was characterized by signs of accelerated aging.

ALT is an enzyme that is produced in liver cells and is naturally found in the blood of healthy individuals. In liver disease, liver cells are damaged and as a consequence, ALT is released into the blood, increasing ALT levels above the normal range. Physicians routinely test blood levels of ALT to monitor the health of a patient’s liver.

ALT level is a clinically important biochemical marker of the severity of liver inflammation and ongoing liver disease. Elevated levels of ALT represent general markers of liver cell death and inflammation without regard to any specific mechanism. However, in later stage cirrhosis patients, ALT levels have been shown to not be elevated above the normal range.

Aspartate aminotransferase (AST) is a second enzyme found in the blood that is produced in the liver and routinely measured by physicians along with ALT. As with ALT, AST is often elevated in liver disease and, like ALT, is considered an overall marker of liver inflammation.

Another important marker of liver cell death is a protein fragment called caspase-cleaved Cytokeratin 18 (cCK18). During apoptosis, a key structural protein within the cell called Cytokeratin 18, or CK18, is specifically cleaved by caspases, which results in the release of cCK18 into the blood stream. cCK18 is easily detected in the blood with a commercially-available test and is a mechanism-specific biomarker of apoptosis and caspase activity.

Unlike ALT, cCK18 is elevated in patients with advanced liver disease and cirrhosis. Importantly, cCK18 is also present in healthy subjects and multiple studies have demonstrated an approximate basal level in healthy subjects. Numerous independent clinical trials and published studies have demonstrated the utility of cCK18 for detecting and gauging the severity of ongoing liver disease across a variety of disease etiologies. These studies have demonstrated correlations between disease and cCK18 levels in patients with ACLF, LC, portal hypertension (PH), HCV, NASH and various other liver disease indications. For example, it has been shown that in HCV patients, the severity of liver disease was correlated with cCK18 levels and apoptosis, such that the more severe the disease, the higher the serum level of cCK18.

In ACLF patients, studies have shown that blood levels of cCK18 were higher in non-surviving patients than in patients that survived. In LC patients, studies have shown that cCK18 levels are elevated and correlate with liver inflammation and cholestasis. cCK18 is a valid and important biomarker of excessive apoptosis in liver disease.

What if you could find out what types of workouts are the most beneficial and effective for your body? What foods you’re intolerant to and which ones you should be including in your diet? Thanks to genetic testing, it’s possible. The future of health and fitness is hyper-personalisation through DNA tests.

Through genetic testing, we can analyse the genetic make-up of each individual and gain a better understanding of our wellness needs. Instead of settling for a generic plan that might work for one person, but not for each individual, you can have access to a fitness plan that is tailored to your DNA, improving the benefits, efficiency and endurance of each individual.

Genetic testing doesn’t only provide valuable information about what the most appropriate workout plan is for each person, but also nutritional advice based on your DNA results. As a result, you’re able to create a personalised nutrition and fitness plan adapted to your needs and provide the best results for your health and wellbeing.

If you want to create a hyper-personalised health and fitness plan, than you should consider getting a DNA test to determine your body’s needs.

High technologies of longevity include the latest new drugs and resources that exist in the world practice for prolonging life.

The rejuvenation program includes only natural products, anti-oxidants, senolytics, polyvitamins, minerals, aminoacids and chelating agents. No secondary effects. These treatments have been created and patented by Dr Elina Manzhalii.

GLI helps you to live healthier and beautiful lifestyle by slowing down the aging process. We recommend high technologies of longevity to people with fatigue, sleep disorder, stress, and hormone syndrome and for prevention of deseases.

Depending on the blood results and the anamnesis of the patient, this treatment can be adapted and focused on specific health problem.

The organization’s vision is to holistically manage wellness, nutrition and health, and to diagnose and treat diseases to significantly change the treatment paradigm for patients by using personalized medicine and cutting edge technologies.